Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Common Equity (2016 - 2026)

Kewaunee Scientific has reported Common Equity over the past 16 years, most recently at $70.7 million for Q1 2026.

  • Quarterly results put Common Equity at $70.7 million for Q1 2026, up 16.24% from a year ago — trailing twelve months through Jan 2026 was $70.7 million (up 16.24% YoY), and the annual figure for FY2025 was $66.2 million, up 20.97%.
  • Common Equity for Q1 2026 was $70.7 million at Kewaunee Scientific, up from $69.9 million in the prior quarter.
  • Over the last five years, Common Equity for KEQU hit a ceiling of $70.7 million in Q1 2026 and a floor of $34.4 million in Q4 2022.
  • Median Common Equity over the past 5 years was $44.1 million (2024), compared with a mean of $49.6 million.
  • Biggest five-year swings in Common Equity: decreased 13.45% in 2022 and later soared 46.38% in 2024.
  • Kewaunee Scientific's Common Equity stood at $34.4 million in 2022, then grew by 22.4% to $42.1 million in 2023, then soared by 40.89% to $59.3 million in 2024, then grew by 17.74% to $69.9 million in 2025, then grew by 1.18% to $70.7 million in 2026.
  • The last three reported values for Common Equity were $70.7 million (Q1 2026), $69.9 million (Q4 2025), and $67.1 million (Q3 2025) per Business Quant data.